Related Experiment Video
Updated: May 3, 2026
06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
36.6K
Memory loss in Alzheimer's disease
1University Hospital Hamburg-Eppendorf, Dept of Psychiatry and Psychotherapy, Hamburg, Germany.
Dialogues in Clinical Neuroscience
|January 25, 2014
Summary
Alzheimer's disease (AD) significantly impairs memory, affecting working and long-term recall early on. Understanding AD memory loss aids diagnosis, grading, and prognosis by examining brain integrity and genetic factors.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Pathology
Background:
- Memory loss, particularly working and long-term declarative memory, is a primary early symptom of Alzheimer's disease (AD).
- Alzheimer's disease pathology impacts memory formation at molecular and neural network levels.
- Individual memory impairment patterns correlate with brain structural and functional integrity.
Purpose of the Study:
- To investigate the mechanisms and manifestations of memory loss in Alzheimer's disease.
- To explore how memory analysis aids in understanding AD subtypes, disease grading, and prognosis.
- To highlight the role of neuropsychological testing in AD diagnosis alongside biomarkers.
Main Methods:
- Analysis of memory functions in Alzheimer's disease patients.
- Correlation of memory impairment patterns with brain integrity parameters.
- Review of molecular, neural network, genetic (ApoE4), and evolutionary factors in AD memory loss.
Main Results:
- Alzheimer's disease pathology disrupts memory formation from molecular to network levels.
- Specific memory deficits correlate with structural and functional brain changes.
- Neuropsychological testing remains crucial for AD diagnosis, complementing biomarker and imaging data.
Conclusions:
- Investigating AD memory loss reveals insights into neural structures (e.g., default mode network), genetic influences, and cognitive evolution.
- Memory analysis is vital for classifying AD subtypes, grading disease severity, and predicting patient outcomes.
- While biomarkers improve early AD diagnosis, comprehensive neuropsychological assessment is fundamental.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:22Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
01:13Amnesia
950
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
950
01:26Higher Mental Functions of Brain: Learning and Memory
2.2K
Memory is one of the most vital higher mental functions of the brain. Memory is closely related to learning because it enables us to retain information and experiences from our past to use them in our present life. It also helps us to remember facts, events, and skills, such as riding a bike or swimming. There are two types of memory — declarative memory, which involves memorizing facts or events, and procedural memory, which enables us to remember how to do something like writing or...
2.2K